Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03781570 · ClinicalTrials.gov registry record
Brain and Genetic Predictors of Individual Differences in Pain and Analgesia
A clinical trial, sponsored by Trustees of Dartmouth College.
- Completed
- Registry status
- 541
- Enrollment target
NCT03781570: Completed study, sponsored by Trustees of Dartmouth College.
NCT03781570 is a clinical trial that has completed, run by Trustees of Dartmouth College. The registered enrollment target is 541 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03781570 has completed, sponsored by Trustees of Dartmouth College.
- COMPLETED
- Registry status
- 541 participants
- Enrollment target
Study Summary
The purpose of the study is to gain a better understanding of pain processing in the brain. Our understanding of how pain is processed in the brain is limited. We are testing for individual differences in pain perception and emotion.
Primary Outcome
Self reported pain using a Visual Analogue Scale (VAS) ranging from 0-100 (with 0 representing "no pain at all" and 100 representing "most intense pain imaginable (in the context of the experiment)). Higher scores indicate more pain. 0 is the minimum value and 100 is the maximum value. This scale is used for both thermal and mechanical pain. Reported values reflect averages of VAS ratings for individual stimuli for each of thermal and mechanical pain.
Interventions
- BEHAVIORAL Placebo Cream
- BEHAVIORAL Control Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 541 participants |
| Start Date | 2018-11-07 |
| Est. Completion | 2023-10-01 |
What the finished NCT03781570 record still lists
NCT03781570 is an observational study that tracks outcomes without assigning an intervention. The registered 541 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Placebo Cream is the first listed.
NCT03781570 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03781570 about?
NCT03781570 is a clinical study titled "Brain and Genetic Predictors of Individual Differences in Pain and Analgesia". The purpose of the study is to gain a better understanding of pain processing in the brain. Our understanding of how pain is processed in the brain is limited. We are testing for individual differences in pain perception and emotion.
What is the current status of trial NCT03781570?
This trial is currently completed. The enrollment target is 541 participants. The study started on 2018-11-07. Estimated completion is 2023-10-01.
What interventions are being tested in trial NCT03781570?
The interventions under investigation include: Placebo Cream (BEHAVIORAL), Control Cream (BEHAVIORAL).
Who is sponsoring clinical trial NCT03781570?
This trial is sponsored by Trustees of Dartmouth College, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04929223 · 542 participants · Phase 1
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- NCT05584670 · 542 participants · Phase 1
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
- NCT04557462 · 540 participants · Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- NCT04956640 · 540 participants · Phase 1
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI